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Systemic mycosis are a major cause of morbidity and mortality among 
immunocompromised (HIV infection, neutropenic and transplanted) and debilitated 
individuals attending health care institutions. Available antifungal compounds are 
scarce and the restricted spectrum of activity, toxicity, and drug interaction limit 
their use. Our group had previously identified three (Z)-5-amino-N'-aryl-1-methyl-
1H-imidazole-4-carbohydrazonamides 1 [aryl= phenyl (1a), 4-fluorophenyl (1b), 3-
fluorophenyl (1c)] as potent antifungal agents [1]. The goal of the present work was 
to elucidate the effect of the compounds on mitochondrial activity of Candida sp. 
and their interference with Nitric oxide (NO) production by macrophages. 
The effect of the imidazole derivatives 1 on mitochondrial reductase activity in C. 
albicans and C. krusei was determined through MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl-2H-tetrazolium bromide] assay. NO production by LPS stimulated 
RAW 264.7 murine macrophages was quantified by the Griess assay. 
All the compounds inhibited mitochondrial activity of C. krusei, being 1a the most 
active (4 µg mL-1). The inhibitory effect was higher in C. krusei when compared to 
C. albicans. All the compounds strongly inhibited NO production by stimulated 
macrophages. Compounds 1c and 1a seem to inhibit iNOS expression. 
In conclusion, an antifungal agent capable of interfering with the immune system 
could enable the design of novel therapeutic strategies for mycosis treatment, 
namely in transplant recipients.  
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